FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Survey shows cancer anxiety has impact well beyond the individual diagnosed

2.

Standardized criteria for amino acid PET imaging could improve diagnosis and treatment of brain metastases

3.

Risk of a second cancer after early breast cancer is low, say new findings

4.

Patients With Melanoma Brain Mets May Fare Better With RT Before Immunotherapy

5.

Gatekeeping May Reduce Pediatric Cancer Trial Participation


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot